|
US2940972A
(en)
|
1957-06-27 |
1960-06-14 |
Thomae Gmbh Dr K |
Tri-and tetra-substituted pteridine derivatives
|
|
US2963481A
(en)
|
1959-11-27 |
1960-12-06 |
Smith Kline French Lab |
6-pteridinecarboxylic acid esters
|
|
US3712892A
(en)
|
1969-08-02 |
1973-01-23 |
Sumitomo Chemical Co |
Quinazolinone derivatives
|
|
JPH05170744A
(ja)
*
|
1991-12-25 |
1993-07-09 |
Toray Dow Corning Silicone Co Ltd |
含窒素芳香族複素環式化合物のアルキル化方法
|
|
EP0743855A1
(en)
|
1994-01-03 |
1996-11-27 |
Acea Pharmaceuticals, Inc. |
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
|
|
DK1028950T3
(da)
|
1997-10-28 |
2003-09-01 |
Warner Lambert Co |
7-substituerede quinazolin-2,4-dioner nyttige som antibakterielle midler
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
JP2004521892A
(ja)
|
2000-12-20 |
2004-07-22 |
メルク エンド カムパニー インコーポレーテッド |
（ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
|
|
JP2003005355A
(ja)
|
2001-06-20 |
2003-01-08 |
Fuji Photo Film Co Ltd |
電子線又はｘ線用ネガ型レジスト組成物
|
|
JP4690043B2
(ja)
|
2002-10-04 |
2011-06-01 |
プラナ バイオテクノロジー リミティッド |
神経に対し活性な化合物
|
|
GB0229281D0
(en)
*
|
2002-12-16 |
2003-01-22 |
Novartis Ag |
Organic compounds
|
|
WO2005007099A2
(en)
|
2003-07-10 |
2005-01-27 |
Imclone Systems Incorporated |
Pkb inhibitors as anti-tumor agents
|
|
PL1673092T3
(pl)
|
2003-10-17 |
2008-01-31 |
4 Aza Ip Nv |
Pochodne pterydyny podstawione heterocyklem i ich zastosowanie w leczeniu
|
|
JP2007510642A
(ja)
*
|
2003-11-03 |
2007-04-26 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
中枢神経系障害の治療のための新規ノルエピネフリン再取込み阻害薬
|
|
RU2358969C2
(ru)
|
2004-02-13 |
2009-06-20 |
Баниу Фармасьютикал Ко., Лтд. |
Конденсированное 4-оксопиримидиновое производное
|
|
WO2005087742A1
(en)
*
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
NZ551004A
(en)
|
2004-04-02 |
2010-07-30 |
Prana Biotechnology Ltd |
Neurologically-active compounds
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
JP2008531538A
(ja)
|
2005-02-25 |
2008-08-14 |
クドス ファーマシューティカルズ リミテッド |
２，４−ジアミノ−ピリドピリミジン誘導体とｍＴＯＲ阻害剤としてのその使用
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
KR100659088B1
(ko)
|
2005-07-15 |
2006-12-21 |
삼성에스디아이 주식회사 |
디플루오로피리딘계 화합물 및 이를 이용한 유기 발광 소자
|
|
JP2009509963A
(ja)
|
2005-09-23 |
2009-03-12 |
スミスクライン・ビーチャム・コーポレイション |
新規化合物
|
|
JP2009528387A
(ja)
|
2006-03-02 |
2009-08-06 |
スミスクライン・ビーチャム・コーポレイション |
Ｐｉ３キナーゼ阻害剤として用いるためのチアゾロン
|
|
US7855194B2
(en)
|
2006-03-27 |
2010-12-21 |
Hoffmann-La Roche Inc. |
Pyrimidine, quinazoline, pteridine and triazine derivatives
|
|
WO2008003149A2
(en)
|
2006-07-06 |
2008-01-10 |
Gilead Sciences , Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
|
US7635683B2
(en)
|
2006-08-04 |
2009-12-22 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl tripeptide hepatitis C virus inhibitors
|
|
CA2659851C
(en)
|
2006-08-23 |
2014-02-25 |
Kudos Pharmaceuticals Limited |
2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
|
|
US8048894B2
(en)
|
2007-04-18 |
2011-11-01 |
Amgen Inc. |
Quinolones and azaquinolones that inhibit prolyl hydroxylase
|
|
US20090099195A1
(en)
|
2007-05-08 |
2009-04-16 |
Astrazeneca Ab |
Therapeutic Compounds 570
|
|
MX2010004074A
(es)
|
2007-10-15 |
2010-07-02 |
Astrazeneca Ab |
Combinacion 059.
|
|
WO2009100406A2
(en)
|
2008-02-07 |
2009-08-13 |
Synta Pharmaceuticals Corp. |
Topical formulations for the treatment of psoriasis
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
US20120021519A1
(en)
|
2008-09-19 |
2012-01-26 |
Presidents And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
|
WO2010042925A2
(en)
|
2008-10-10 |
2010-04-15 |
Vm Discovery Inc. |
Compositions and methods for treating alcohol use disorders, pain and other diseases
|
|
WO2010107768A1
(en)
|
2009-03-18 |
2010-09-23 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
|
US8691187B2
(en)
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
|
US8722692B2
(en)
|
2009-07-30 |
2014-05-13 |
Jianwei Che |
Compounds and compositions as Syk kinase inhibitors
|
|
WO2011014039A1
(en)
|
2009-07-31 |
2011-02-03 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
|
US20110124597A1
(en)
|
2009-09-25 |
2011-05-26 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
|
MX2012004846A
(es)
|
2009-10-29 |
2012-10-05 |
Genosco |
Inhibidores de cinasa.
|
|
BR112012022868A2
(pt)
*
|
2010-03-16 |
2018-06-05 |
Merck Patent Gmbh |
morfolinilquinazolinas
|
|
US9139592B2
(en)
|
2010-06-14 |
2015-09-22 |
Trt Pharma Inc. |
Modulators of Nrf2 and uses thereof
|
|
US10260097B2
(en)
|
2011-06-02 |
2019-04-16 |
Almac Diagnostics Limited |
Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
KR101497124B1
(ko)
|
2011-11-28 |
2015-03-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 포함하는 유기전기소자 및 그 전자 장치
|
|
SG11201404743TA
(en)
|
2012-02-08 |
2014-09-26 |
Janssen R & D Ireland |
Piperidino-pyrimidine derivatives for the treatment of viral infections
|
|
CN103374021B
(zh)
|
2012-04-21 |
2015-10-28 |
通化济达医药有限公司 |
含有锌结合基的吡啶并嘧啶类HDAC和mTOR抑制剂
|
|
WO2014146249A1
(en)
*
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
|
|
EP3027616B1
(en)
|
2013-07-30 |
2018-01-10 |
Boehringer Ingelheim International GmbH |
Azaindole compounds as modulators of rorc
|
|
ES2750236T3
(es)
|
2013-12-09 |
2020-03-25 |
UCB Biopharma SRL |
Derivados heteroaromáticos bicíclicos condensados como moduladores de la actividad del TNF
|
|
KR20150080966A
(ko)
|
2014-01-02 |
2015-07-13 |
최돈수 |
유기 전기 발광 소자용 발광 재료, 이를 이용한 유기 전기 발광 소자 및 유기 전기 발광 소자용 재료
|
|
KR20160060572A
(ko)
|
2014-11-19 |
2016-05-30 |
주식회사 엠비케이 |
유기 발광 화합물, 잉크 조성물, 유기 발광 소자 및 전자 기기
|
|
RU2717665C2
(ru)
|
2015-04-15 |
2020-03-24 |
Ф. Хоффманн-Ля Рош Аг |
Пиридопиримидиноны и их применение в качестве модуляторов рецептора n-метил-d-аспартата
|
|
US10403826B2
(en)
|
2015-05-07 |
2019-09-03 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
EP3335254B1
(de)
|
2015-08-11 |
2020-04-08 |
Merck Patent GmbH |
Materialien für organische elektrolumineszenzvorrichtungen
|
|
WO2017031427A1
(en)
|
2015-08-19 |
2017-02-23 |
3-V Biosciences, Inc. |
COMPOUNDS AND METHODS FOR INHIBITING mTOR
|
|
US10573692B2
(en)
|
2016-04-06 |
2020-02-25 |
Samsung Display Co., Ltd. |
Organic light-emitting device having a sealing thin film encapsulation portion
|
|
KR102606277B1
(ko)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
|
PL3442947T3
(pl)
|
2016-04-15 |
2023-10-02 |
Epizyme, Inc. |
Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2
|
|
MX2019003790A
(es)
|
2016-10-04 |
2019-09-26 |
Enanta Pharm Inc |
Analogos de isoxazol como agonistas de fxr y metodos de uso de los mismos.
|
|
US11283028B2
(en)
|
2016-10-05 |
2022-03-22 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent compound and organic electroluminescent device comprising the same
|
|
CN109790183A
(zh)
|
2016-12-13 |
2019-05-21 |
广州华睿光电材料有限公司 |
金属有机配合物及其应用、混合物、有机电子器件
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
TW201843143A
(zh)
|
2017-03-13 |
2018-12-16 |
德商麥克專利有限公司 |
含有芳基胺結構之化合物
|
|
WO2018169352A1
(en)
|
2017-03-16 |
2018-09-20 |
Rohm And Haas Electronic Materials Korea Ltd. |
Organic electroluminescent device
|
|
KR102335935B1
(ko)
|
2017-03-22 |
2021-12-06 |
덕산네오룩스 주식회사 |
유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
US20200113901A1
(en)
|
2017-03-31 |
2020-04-16 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
|
KR102389204B1
(ko)
|
2017-04-18 |
2022-04-21 |
덕산네오룩스 주식회사 |
유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
|
CN110996945A
(zh)
|
2017-06-13 |
2020-04-10 |
联邦科学技术研究组织 |
抗病毒药物
|
|
EP3689866A4
(en)
|
2017-09-26 |
2021-07-07 |
Nippon Soda Co., Ltd. |
QUINOLINE COMPOUND AND BACTERICIDAL AGENT FOR AGRICULTURE AND HORTICULTURE
|
|
JP2021500326A
(ja)
|
2017-10-18 |
2021-01-07 |
エピザイム，インコーポレイティド |
血液障害の予防又は処置にｅｈｍｔ２阻害剤を使用する方法
|
|
AU2018353139A1
(en)
|
2017-10-18 |
2020-06-04 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors in immunotherapies
|
|
CN108484680B
(zh)
|
2018-01-31 |
2020-12-11 |
马鞍山南京大学高新技术研究院 |
一类双硫代芳环/芳杂环磷酸化合物作为辅助配体的铱配合物
|
|
CA3098574A1
(en)
|
2018-05-04 |
2019-11-07 |
Amgen Inc. |
Kras g12c inhibitors and methods of using the same
|
|
US12453279B2
(en)
|
2018-08-22 |
2025-10-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
CN109265457A
(zh)
|
2018-11-01 |
2019-01-25 |
中国药科大学 |
一种利用氧化芳构化构建吡啶并嘧啶二酮骨架的新方法
|
|
WO2020231739A2
(en)
|
2019-05-10 |
2020-11-19 |
Antidote Ip Holdings, Llc |
Compounds and methods for treating cancer
|
|
CN110283171A
(zh)
|
2019-07-17 |
2019-09-27 |
鼎泰(南京)临床医学研究有限公司 |
一类含有吡啶并嘧啶-4-胺类结构的化合物、药物组合物以及其应用
|
|
US11820783B2
(en)
|
2019-09-06 |
2023-11-21 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
|
TW202208355A
(zh)
|
2020-05-04 |
2022-03-01 |
美商安進公司 |
作為骨髓細胞觸發受體2促效劑之雜環化合物及使用方法
|
|
BR112022022184A2
(pt)
|
2020-05-04 |
2023-01-17 |
Takeda Pharmaceuticals Co |
Derivados de n-(piperidin-4-il)benzamida agindo luminalmente
|
|
JP7741100B2
(ja)
|
2020-05-04 |
2025-09-17 |
アムジェン インコーポレイテッド |
ミエロイド細胞に発現するトリガー受容体２アゴニストとしての複素環化合物及び使用方法
|
|
IL297864A
(en)
|
2020-05-04 |
2023-01-01 |
Adama Makhteshim Ltd |
Mixtures and compositions comprising 5-fluoro-4-imino-3- methyl-1-tosyl-3,4-dihydropyrimidin-2-one, and methods of use thereof
|
|
CN111454265B
(zh)
|
2020-05-07 |
2021-08-24 |
宁波卢米蓝新材料有限公司 |
一种稠杂环化合物及其制备方法和应用
|
|
CA3244298A1
(en)
|
2022-01-11 |
2023-07-20 |
Regeneron Pharmaceuticals, Inc. |
TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL VARIANTS 2 (TREM2) AND ITS USES IN THE TREATMENT OF ALZHEIMER'S DISEASE
|